VEGFA and triple-A syndrome: In our original study, we observed an increase of this biomarker (after treatment with EET-A and AAA in adult SHR), which we have considered as a beneficial sign of improved kidney function, especially considering that it was shown that VEGF-A stimulates the synthesis of NO (Robinson et al., 2010).